{{Rsnum
|rsid=1495448
|Gene=MAGI1
|Chromosome=3
|position=65825239
|Orientation=plus
|GMAF=0.4288
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=MAGI1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 31.9 | 47.8 | 20.4
| HCB | 59.9 | 38.7 | 1.5
| JPT | 60.2 | 32.7 | 7.1
| YRI | 15.0 | 45.6 | 39.5
| ASW | 15.8 | 56.1 | 28.1
| CHB | 59.9 | 38.7 | 1.5
| CHD | 49.5 | 42.2 | 8.3
| GIH | 24.8 | 51.5 | 23.8
| LWK | 16.4 | 46.4 | 37.3
| MEX | 48.3 | 37.9 | 13.8
| MKK | 19.2 | 42.3 | 38.5
| TSI | 27.5 | 49.0 | 23.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1495448
|Name_s=
|Gene_s=MAGI1
|Feature=
|Evidence=PubMed ID:20031579
|Annotation=This SNP was identified in a GWAS performed for 4221 Sardinian individuals as being significantly associated with Carotid-femoral pulse wave velocity, which is a measure of arterial stiffness. The association was replicated in a second Sardinian cohort (1857 subjects) for a combined p = 1.06 x 10(-5), but when tested in a cohort of 813 Old-Order Amish of Lancaster, PA, the overall association was weakened.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA165111685
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1495448
|overall_frequency_n=72
|overall_frequency_d=128
|overall_frequency=0.5625
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=62
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}
{{on chip | Affy GenomeWide 6}}